Toggle My BrainyQuote
Quote of the Day
I support GMOs. And we should label them. We should label them because that is the very best thing we can do for public acceptance of agricultural biotech. And we should label them because there's absolutely nothing to hide.
When a nanotech company matures and becomes a real business, it becomes something else. It becomes a biotech company or a cleantech company or a memory chip company. Nanotechnology has fueled the core innovations in electronics and energy.
I'm an investor in a number of biotech companies, partly because of my incredible enthusiasm for the great innovations they will bring.
I don't think that a mutual fund that invests exclusively in biotech start-ups or invests exclusively in companies in Thailand offers any great safety or diversification.
The 1st Congressional District contains almost half of the biotech and biomedical companies in Washington, and my job often allows me to meet the people responsible for this exciting research.
Industries with rapid change are the enemy of the investor. Tech businesses, particularly biotech, is a problem from that point of view. All industries work with change, but you should ideally be investing in businesses with a low rate of change, not a high rate of change.
The first generation of biotech physically cut and pasted from one organism to another. You learned that taxol helped cure cancer, then you found the source organism and extracted the genes to make your drug. Now physical science is becoming information science.
It was a chance encounter with a biotech entrepreneur from Ireland that got me started as an entrepreneur in India, because I partnered this Irish company in setting up India's first biotech company.
The trouble is the field of science, medicine, universities, biotech companies - you name it - have been so splintered, layers, sub-divided, hacked that people can spend their entire career studying one tiny little cog of life.
We are working with a biotech company, Calypte, which has designed a urine test for the HIV antibody.
One of the things that launched the strength in biotech is when the pharmaceutical industry itself got a little slow.
Optimization tells us precisely how to diversify the portfolio, whether I should have 12% in semiconductors or 4% in biotech, etc., and it literally tells me how to diversify not only the industry groups but the stocks.
One of the problems in the biotech world is the lack of women in leadership roles, and I'd like to see that change by walking the walk.
Get Social with BrainyQuote
Follow BrainyQuote on Facebook, Twitter and Google+ to share inspiring quotes with friends.
Join us on
Follow us on
Follow us on
Quote of the Day
BQ on Facebook
BQ on Twitter
BQ on Pinterest
BQ on Google+
BQ on Instagram
Quote Of The Day Feeds
Quote of the Day Email
© 2001 - 2015 BrainyQuote